Blunted muscle angiogenic trainingresponse in COPD patients versus sedentary controls

European Respiratory Journal

Volumn 41, Issue 4, 2013, Pages 806-814

  Gouzi, Fares ^a,b   Préfaut, Christian ^a   Abdellaoui, Aldjia ^a,c   Roudier, Emilie ^d   De Rigal, Philippe ^b   Molinari, Nicolas ^e   Laoudj Chenivesse, Dalila ^a   Mercier, Jacques ^a   Birot, Olivier ^d   Hayot, Maurice ^a  

^a UNIV MONTPELLIER   (France)

^b Pulmonary Rehabilitation Center 'La Solane'   (France)

^c Fontalvie Group   (France)

^d UMR 729 MISTEA   (France)

^e York University   (Canada)

Author keywords

Chronic diseases; Exercise testing; Myopathy in COPD; Rehabilitation programmes; Remodelling; Vascular remodelling

Indexed keywords

THROMBOSPONDIN 1; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CAPILLARY TO FIBRE RATIO; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDURANCE TRAINING; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUSCLE CAPILLARY; MUSCLE EXERCISE; MUSCLE FUNCTION; NAMED GROUPS OF PERSONS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REHABILITATION; SEDENTARY HEALTHY SUBJECT; VASTUS LATERALIS MUSCLE;

ADAPTATION, PHYSIOLOGICAL; AGED; BIOPSY; CAPILLARIES; CASE-CONTROL STUDIES; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLES; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEDENTARY LIFESTYLE; THROMBOSPONDINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875847324     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00053512     Document Type: Article

References (44)

1. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182: 693-718.
2. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26: 703-719.
3. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 2002; 19: 617-625.
4. Eliason G, Abdel-Halim SM, Piehl-Aulin K, et al. Alterations in the muscle-to-capillary interface in patients with different degrees of chronic obstructive pulmonary disease. Respir Res 2010; 11: 97.
5. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
6. Bernard S, Whittom F, Leblanc P, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 896-901.
7. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30: 1467-1474.
8. Vogiatzis I, Stratakos G, Simoes DC, et al. Effects of rehabilitative exercise on peripheral muscle TNFa, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax 2007; 62: 950-956.
9. Gosker HR, Schrauwen P, Broekhuizen R, et al. Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab 2006; 290: E976-E981.
10. Lewis MI, Fournier M, Storer TW, et al. Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol 2007; 103: 1299-1310.
11. Russell AP, Feilchenfeldt J, Schreiber S, et al. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-c coactivator-1 and peroxisome proliferator-activated receptor-A in skeletal muscle. Diabetes 2003; 52: 2874-2881.
12. Vogiatzis I, Simoes DC, Stratakos G, et al. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J 2010; 36: 301-310.
13. Wallberg-Henriksson H, Gunnarsson R, Henriksson J, et al. Influence of physical training on formation of muscle capillaries in type I diabetes. Diabetes 1984; 33: 851-857.
14. Kiilavuori K, Naveri H, Salmi T, et al. The effect of physical training on skeletal muscle in patients with chronic heart failure. Eur J Heart Fail 2000; 2: 53-63.
15. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1435-1445.
16. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
17. Voorrips LE, Ravelli AC, Dongelmans PC, et al. A physical activity questionnaire for the elderly. Med Sci Sports Exerc 1991; 23: 974-979.
18. Steele BG, Holt L, Belza B, et al. Quantitating physical activity in COPD using a triaxial accelerometer. Chest 2000; 117: 1359-1367.
19. Gouzi F, Prefaut C, Abdellaoui A, et al. Evidence of an early physical activity reduction in chronic obstructive pulmonary disease patients. Arch Phys Med Rehabil 2011; 92: 1611-1617.
20. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
21. ATS statement. guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
22. Vallet G, Ahmaidi S, Serres I, et al. Comparison of two training programmes in chronic airway limitation patients: standardized versus individualized protocols. Eur Respir J 1997; 10: 114-122.
23. Pre'faut C, Gautier-Dechaud V, Fuchs-Climent D, et al. Quality of life in patients with chronic obstructive pulmonary disease on long-term oxygen therapy: role of exercise training. In: Advances in Cardiopulmonary Rehabilitation. Champaign, Human Kinetics, 2000; pp. 177-186.
24. Hayot M, Michaud A, Koechlin C, et al. Skeletal muscle microbiopsy: a validation study of a minimally invasive technique. Eur Respir J 2005; 25: 431-440.
25. Abdellaoui A, Prefaut C, Gouzi F, et al. Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study. Eur Respir J 2011; 38: 781-788.
26. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. In: Verbeke G, Molenberghs G, eds. Linear Mixed Models for Longitudinal Data. 2nd Edn. New York, Springer-Verlag, 2009; p. 570.
27. Horowitz JF, Sidossis LS, Coyle EF. High efficiency of type I muscle fibers improves performance. Int J Sports Med 1994; 15: 152-157.
28. Vago P, Mercier J, Ramonatxo M, et al. Is ventilatory anaerobic threshold a good index of endurance capacity? Int J Sports Med 1987; 8: 190-195.
29. Nordsborg NB, Lundby C, Leick L, et al. Relative workload determines exercise-induced increases in PGC-1a mRNA. Med Sci Sports Exerc 2010; 42: 1477-1484.
30. Puente-Maestu L, Lazaro A, Tejedor A, et al. Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD. Thorax 2011; 66: 121-127.
31. Hepple RT, Hogan MC, Stary C, et al. Structural basis of muscle O2 diffusing capacity: evidence from muscle function in situ. J Appl Physiol 2000; 88: 560-566.
32. Hepple RT, Agey PJ, Hazelwood L, et al. Increased capillarity in leg muscle of finches living at altitude. J Appl Physiol 1998; 85: 1871-1876.
33. Richardson RS, Grassi B, Gavin TP, et al. Evidence of O2 supplydependent V9O2max in the exercise-trained human quadriceps. J Appl Physiol 1999; 86: 1048-1053.
34. Simoneau JA, Lortie G, Boulay MR, et al. Human skeletal muscle fiber type alteration with high-intensity intermittent training. Eur J Appl Physiol Occup Physiol 1985; 54: 250-253.
35. Hepple RT, Mackinnon SL, Thomas SG, et al. Quantitating the capillary supply and the response to resistance training in older men. Pflugers Arch 1997; 433: 238-244.
36. Olfert IM, Birot O. Importance of anti-angiogenic factors in the regulation of skeletal muscle angiogenesis. Microcirculation 2011; 18: 316-330.
37. Olfert IM, Howlett RA, Tang K, et al. Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol 2009; 587: 1755-1767.
38. Korpisalo P, Hytonen JP, Laitinen JT, et al. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy. Eur Heart J 2011; 32: 1664-1672.
39. Malek MH, Olfert IM. Global deletion of thrombospondin-1 increases cardiac and skeletal muscle capillarity and exercise capacity in mice. Exp Physiol 2009; 94: 749-760.
40. Roudier E, Gineste C, Wazna A, et al. Angio-adaptation in unloaded skeletal muscle: new insights into an early and muscle type-specific dynamic process. J Physiol 2010; 588: 4579-4591.
41. Esposito F, Reese V, Shabetai R, et al. Isolated quadriceps training increases maximal exercise capacity in chronic heart failure: the role of skeletal muscle convective and diffusive oxygen transport. J Am Coll Cardiol 2011; 58: 1353-1362.
42. Wang J, Zhou S, Bronks R, et al. Effects of supervised treadmill walking training on calf muscle capillarization in patients with intermittent claudication. Angiology 2009; 60: 36-41.
43. Moazzami K, Majdzadeh R, Nedjat S. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia. Cochrane Database Syst Rev 2011; 12: CD008347.
44. Vogiatzis I, Athanasopoulos D, Stratakos G, et al. Exercise-induced skeletal muscle deoxygenation in O-supplemented COPD patients. Scand J Med Sci Sports 2009; 19: 364-372.